J Schofer

Summary

Affiliation: Center for Cardiology and Vascular Intervention
Country: Germany

Publications

  1. ncbi Are drug-eluting stents a panacea for patients with coronary heart disease?
    Joachim Schofer
    Centre for Cardiology and Vascular Intervention, Othmarscher Kirchenweg 168, D 22763 Hamburg, Germany
    Lancet 364:558-9. 2004
  2. ncbi Coronary restenosis after implantation of drug-eluting stents
    J Schofer
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    Minerva Cardioangiol 53:43-8. 2005
  3. ncbi Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials
    Rainer Hoffmann
    Medical Clinic I, University Hospital Aachen, Aachen, Germany
    Catheter Cardiovasc Interv 66:499-506. 2005
  4. ncbi A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study
    Mitchell W Krucoff
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 51:1543-52. 2008
  5. ncbi Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies
    Joachim Schofer
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    Herz 29:195-200. 2004
  6. ncbi Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)
    Joachim Schofer
    Centre for Cardiology and Vascular Intervention, Othmarscher Kirchenweg 168, D 22763, Hamburg, Germany
    Lancet 362:1093-9. 2003
  7. ncbi Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials
    Michael Schlüter
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    J Am Coll Cardiol 45:10-3. 2005
  8. ncbi Angiographic and clinical outcomes at 8 months of cutting balloon angioplasty and beta-brachytherapy for native vessel in-stent restenosis (BETACUT): results from a stopped randomized controlled trial
    Michael Schlüter
    Hamburg University Cardiovascular Center, Hamburg, Germany
    Catheter Cardiovasc Interv 66:320-6. 2005
  9. ncbi Focal ischemia of the brain after neuroprotected carotid artery stenting
    Michael Schlüter
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    J Am Coll Cardiol 42:1007-13. 2003
  10. ncbi [Mitral valve reconstruction without cardiopulmonary bypass. Border zone between cardiac surgery and interventional cardiology]
    Thilo Tübler
    Universitäres Herz und Gefässzentrum Hamburg GmbH, Hamburg
    Herz 31:406-12. 2006

Detail Information

Publications38

  1. ncbi Are drug-eluting stents a panacea for patients with coronary heart disease?
    Joachim Schofer
    Centre for Cardiology and Vascular Intervention, Othmarscher Kirchenweg 168, D 22763 Hamburg, Germany
    Lancet 364:558-9. 2004
  2. ncbi Coronary restenosis after implantation of drug-eluting stents
    J Schofer
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    Minerva Cardioangiol 53:43-8. 2005
    ....
  3. ncbi Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials
    Rainer Hoffmann
    Medical Clinic I, University Hospital Aachen, Aachen, Germany
    Catheter Cardiovasc Interv 66:499-506. 2005
    ....
  4. ncbi A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study
    Mitchell W Krucoff
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 51:1543-52. 2008
    ....
  5. ncbi Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies
    Joachim Schofer
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    Herz 29:195-200. 2004
    ..The incomplete evidence to date is that implantation of sirolimus-eluting stents in patients with AMI is safe and effective...
  6. ncbi Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)
    Joachim Schofer
    Centre for Cardiology and Vascular Intervention, Othmarscher Kirchenweg 168, D 22763, Hamburg, Germany
    Lancet 362:1093-9. 2003
    ..We investigated the risk of restenosis with use of sirolimus-eluting stents compared with bare-metal stents to assess possible differences...
  7. ncbi Direct stenting of native de novo coronary artery lesions with the sirolimus-eluting stent: a post hoc subanalysis of the pooled E- and C-SIRIUS trials
    Michael Schlüter
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    J Am Coll Cardiol 45:10-3. 2005
    ..We sought to assess the impact of direct stenting (DS) using the sirolimus-eluting stent (SES) on angiographic and clinical outcomes...
  8. ncbi Angiographic and clinical outcomes at 8 months of cutting balloon angioplasty and beta-brachytherapy for native vessel in-stent restenosis (BETACUT): results from a stopped randomized controlled trial
    Michael Schlüter
    Hamburg University Cardiovascular Center, Hamburg, Germany
    Catheter Cardiovasc Interv 66:320-6. 2005
    ..CB angioplasty appears to be as safe and efficacious as SB angioplasty in beta-radiation treatment of patients with predominantly diffuse native vessel ISR. It was decided to discontinue the trial...
  9. ncbi Focal ischemia of the brain after neuroprotected carotid artery stenting
    Michael Schlüter
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    J Am Coll Cardiol 42:1007-13. 2003
    ..This study sought to assess the incidence of cerebral ischemia in nonselected patients undergoing neuroprotected carotid angioplasty and stenting (CAS) without preceding multiple-vessel diagnostic angiography...
  10. ncbi [Mitral valve reconstruction without cardiopulmonary bypass. Border zone between cardiac surgery and interventional cardiology]
    Thilo Tübler
    Universitäres Herz und Gefässzentrum Hamburg GmbH, Hamburg
    Herz 31:406-12. 2006
    ..In this article, the authors focus on the available data as well as on the advantages and disadvantages of the different approaches...
  11. ncbi Direct stenting with sirolimus-eluting stents
    Michael Schlüter
    Hamburg University Cardiovascular Center, Hamburg, Germany
    Am Heart Hosp J 3:182-6, 192. 2005
    ..Since a randomized trial of implantation strategies is lacking, there is no conclusive evidence as to the hypothesized superiority of direct over predilated stenting in suitable coronary lesions...
  12. ncbi [The femoral artery: the most complex peripheral vessel]
    Hans Krankenberg
    Universitäres Herz und Gefässzentrum Hamburg GmbH, 22527 Hamburg
    Herz 31:137-41. 2006
    ..Only the use of self-expanding nitinol stents appears to improve the mid-term results of catheter-based interventional SFA treatment...
  13. ncbi Balloon-protected carotid artery stenting: relationship of periprocedural neurological complications with the size of particulate debris
    T Tübler
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    Circulation 104:2791-6. 2001
    ..A correlation of the size of captured particles with the incidence of periprocedural neurological complications (PNCs) has not been attempted...
  14. ncbi Clinical outcome of patients with and without renal impairment undergoing a minimally invasive LIMA-to-LAD bypass operation
    F C Riess
    Heart Center Hamburg, Albertinen Hospital and Center for Cardiology, Hamburg, Germany
    Heart Surg Forum 3:313-8. 2000
    ..We investigated the outcome of patients with and without renal impairment treated by off-pump coronary artery surgery...
  15. ncbi Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve
    Hendrik Treede
    Department of Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany
    J Thorac Cardiovasc Surg 140:897-903. 2010
    ..The Direct Flow Medical aortic valve (Direct Flow Medical, Inc, Santa Rosa, Calif) is a nonmetallic tissue valve prosthesis intended to treat patients with severe aortic stenosis at high risk for surgery...
  16. ncbi Feasibility and efficacy of balloon-based neuroprotection during carotid artery stenting in a single-center setting
    Michael Schlüter
    Center of Cardiology and Vascular Intervention, Hamburg, Germany
    J Am Coll Cardiol 40:890-5. 2002
    ..It is associated with a 3.1% rate of major periprocedural neurologic complications. Adverse neurologic reactions to balloon occlusion may prohibit effective use of the system in about 2% of patients...
  17. ncbi Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study
    Joachim Schofer
    Medical Care Center Professor Mathey, Professor Schofer Hamburg University Cardiovascular Center Hamburg, Hamburg, Germany
    Circulation 120:326-33. 2009
    ..Percutaneous mitral annuloplasty has the potential to serve as a therapeutic adjunct to standard medical care...
  18. ncbi Impact of diabetes, patient age, and gender on the 30-day incidence of stroke and death in patients undergoing carotid artery stenting with embolus protection: a post-hoc subanalysis of a prospective multicenter registry
    Michael Schlüter
    Hamburg University Cardiovascular Center, Hamburg, Germany
    J Endovasc Ther 14:271-8. 2007
    ..To assess the impact of diabetes, patient age, and gender on major periprocedural (30-day) complications (major and minor strokes, all-cause deaths) following carotid artery stenting (CAS)...
  19. ncbi Saphenous vein graft stenting using a novel filter device for distal protection
    Michael Schlüter
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    Am J Cardiol 91:736-9. 2003
  20. ncbi Congenital fistula between the left internal mammary artery (LIMA) and the pulmonary artery: cause of LIMA bypass occlusion?
    Friedrich Christian Riess
    Department of Cardiac Surgery, Albertinen Hospital, Hamburg, Germany
    Heart Surg Forum 7:E403-4. 2004
    ..From this case we conclude that angiography of the IMA to detect malformations preoperatively should be mandatory in all cases of arterial coronary revascularization using IMA bypasses...
  21. ncbi Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses
    Erick Schampaert
    Cardiology Division, Hopital du Sacre Coeur de Montreal, Montreal, Quebec, Canada
    Am J Cardiol 98:36-41. 2006
    ....
  22. ncbi Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials
    Dean J Kereiakes
    Heart Center of Greater Cincinnati and the Lindner Center for Research and Education at The Christ Hospital, Ohio Heart and Vascular Center Inc, Cincinnati, Ohio 45219, USA
    J Am Coll Cardiol 48:21-31. 2006
    ..The purpose of this research was to determine the relative safety and efficacy of multiple (> or =2) overlapping Cypher sirolimus-eluting stents (SES) (Johnson & Johnson, New Brunswick, New Jersey)...
  23. ncbi Endovascular treatment of in-stent restenosis after carotid artery stenting: immediate and midterm results
    Bernhard Reimers
    Cardiology Department, Mirano Hospital, Italy
    J Endovasc Ther 13:429-35. 2006
    ..To evaluate the immediate and midterm outcome and analyze the debris captured after repeat endovascular intervention for the treatment of in-stent restenosis after carotid artery stenting (CAS)...
  24. ncbi Cause of death with bare metal and sirolimus-eluting stents
    David R Holmes
    Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Heart J 27:2815-22. 2006
    ..There was no significant difference in either the frequency or the cause of death with implantation of either sirolimus-eluting or bare metal stents...
  25. ncbi Gender-specific outcomes after sirolimus-eluting stent implantation
    Emilia Solinas
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 50:2111-6. 2007
    ..We examined the impact of gender on outcomes of patients undergoing percutaneous coronary intervention using sirolimus-eluting stents (SES)...
  26. ncbi Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 356:998-1008. 2007
    ..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
  27. ncbi European carotid PROCAR Trial: prospective multicenter trial to evaluate the safety and performance of the ev3 Protégé stent in the treatment of carotid artery stenosis--1- and 6-month follow-up
    Jennifer Sugita
    CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany
    J Interv Cardiol 19:215-21. 2006
    ..The incidence of MANEs for the Protégé stent is comparable to the incidence of these events in other recent carotid stent studies and standard carotid endarterectomy (CEA)...
  28. ncbi High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial
    Eberhard Grube
    J Am Coll Cardiol 44:1368-72. 2004
    ..Santa Clara, California/Boston Scientific Corp., Natick, Massachusetts) versus uncoated control stents (n = 140) in focal, de novo coronary lesions...
  29. ncbi Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris
    Campbell Rogers
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, Mass 02115, USA
    Circulation 109:1735-40. 2004
    ..We used a novel method of microparticle size assessment to measure volume and characterize individual sizes of particles captured by the PercuSurge GuardWire balloon or a vascular filter during saphenous vein graft stenting...
  30. ncbi Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents
    Laura Mauri
    Brigham and Women's Hospital, Boston, Mass 02116, USA
    Circulation 111:321-7. 2005
    ..Late loss is monotonically correlated with the probability of restenosis and yields a more efficient estimate of the restenosis process in the era of lower binary restenosis rates...
  31. ncbi Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT)
    Remo Albiero
    Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:943-9. 2004
    ..e., percutaneous transluminal coronary angioplasty [PTCA]) for the treatment of patients with coronary in-stent restenosis (ISR)...
  32. ncbi Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients
    Bernhard Reimers
    Cardiology Department, Mirano, Italy
    Am J Med 116:217-22. 2004
    ..The incidence of major neurologic complications in this study was lower than in previous reports of carotid artery stenting without cerebral protection...
  33. ncbi Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry
    Philip Urban
    La Tour Hospital, Geneva, Switzerland
    Circulation 113:1434-41. 2006
    ..The e-Cypher registry monitored the safety and efficacy of SES currently implanted worldwide in daily practice...
  34. ncbi Lessons from the E-SIRIUS trial
    Joachim Schofer
    Ital Heart J 5:1-2. 2004
  35. ncbi Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry
    Bernhard Reimers
    Cardiology Department, Ospedale Civile, Mirano, Italy
    J Endovasc Ther 12:156-65. 2005
    ..Ma device, which prevents cerebral embolization by proximal endovascular blockage of blood flow in the internal and external carotid arteries...
  36. ncbi Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up
    Friedrich Christian Riess
    Heart Center Hamburg, Albertinen Krankenhaus, Department of Cardiac Surgery, Hamburg Othmarschen, Germany
    Ann Thorac Surg 73:1849-55. 2002
    ..We investigated the clinical follow-up of 57 patients with multivessel disease undergoing this procedure in the last 4 years...
  37. ncbi Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percu
    Alec Vahanian
    Hopital Bichat, Paris, France
    Eur Heart J 29:1463-70. 2008
    ..To critically review the available transcatheter aortic valve implantation techniques and their results, as well as propose recommendations for their use and development...
  38. ncbi Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents
    Eugenia Nikolsky
    Columbia University Medical Center, Center for Interventional Vascular Therapy and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Catheter Cardiovasc Interv 71:896-906. 2008
    ..We assessed the outcomes in diabetic patients undergoing percutaneous coronary intervention (PCI) using sirolimus-eluting stents (SES) as a function of treatment with glycoprotein (GP) IIb/IIIa inhibitors...